Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects

EM Marco, MS García-Gutiérrez… - Frontiers in behavioral …, 2011 - frontiersin.org
Public concern on mental health has noticeably increased given the high prevalence of
neuropsychiatric disorders. Cognition and emotionality are the most affected functions in …

The role of the endocannabinoid system in eating disorders: pharmacological implications

EM Marco, SY Romero-Zerbo, MP Viveros… - Behavioural …, 2012 - journals.lww.com
The endocannabinoid (eCB) system is a widespread intercellular signalling mechanism that
plays a critical role in body homoeostasis. It is located in key points involved in food intake …

Endocannabinoid system in psychotic and mood disorders, a review of human studies

R Garani, JJ Watts, R Mizrahi - Progress in Neuro-Psychopharmacology …, 2021 - Elsevier
Despite widespread evidence of endocannabinoid system involvement in the
pathophysiology of psychiatric disorders, our understanding remains rudimentary. Here we …

Endocannabinoid system components as potential biomarkers in psychiatry

F Navarrete, MS García-Gutiérrez… - Frontiers in …, 2020 - frontiersin.org
The high heterogeneity of psychiatric disorders leads to a lack of diagnostic precision.
Therefore, the search of biomarkers is a fundamental aspect in psychiatry to reach a more …

The endocannabinoid system in mental disorders: Evidence from human brain studies

I Ibarra-Lecue, F Pilar-Cuéllar, C Muguruza… - Biochemical …, 2018 - Elsevier
Mental disorders have a high prevalence compared with many other health conditions and
are the leading cause of disability worldwide. Several studies performed in the last years …

Cannabinoids and their therapeutic applications in mental disorders

M Scherma, AL Muntoni, G Riedel… - Dialogues in clinical …, 2020 - Taylor & Francis
Mental disorders represent a significant public health burden worldwide due to their high
prevalence, chronically disabling nature, and substantial impact on quality of life. Despite …

Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders

KY Vinod, BL Hungund - Expert opinion on therapeutic targets, 2006 - Taylor & Francis
G-protein-coupled receptor (GPCR)-mediated signalling is the most widely used signalling
mechanism in cells, and its regulation is important for various physiological functions. The …

Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders

AC Campos, MV Fogaça, FF Scarante… - Frontiers in …, 2017 - frontiersin.org
Beneficial effects of cannabidiol (CBD) have been described for a wide range of psychiatric
disorders, including anxiety, psychosis, and depression. The mechanisms responsible for …

Integrating endocannabinoid signalling in depression

T Rana, T Behl, A Sehgal, V Mehta, S Singh… - Journal of molecular …, 2021 - Springer
Depression is a common mental disorder and is the leading cause of suicide globally.
Because of the significant diversity in mental disorders, accurate diagnosis is difficult …

Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview

GM Mandolini, M Lazzaretti, A Pigoni… - Epidemiology and …, 2018 - cambridge.org
Cannabidiol (CBD) represents a new promising drug due to a wide spectrum of
pharmacological actions. In order to relate CBD clinical efficacy to its pharmacological …